Element Biosciences Delivers 1 Billion Reads and Provides Industry's Lowest Cost for Single-Cell Sequencing

Element Biosciences, Inc. - developer of an innovative DNA sequencing platform set to disrupt the genomics industry - today announced updated specifications to their AVITI System, increasing the platform's specifications from 800 million reads per flow cell to 1.0 billion reads per flow cell*, further reducing the price per Gigabase (or run).